Sage Parson
Adult Health · Austin, TXNPI 1649823360
Payments from drug & device makers
Across 21 payments — averaging $22.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$185
- Avanir Pharmaceuticals, Inc.$127
- Teva Pharmaceuticals USA, Inc.$59
- Neurocrine Biosciences, Inc.$44
- Mylan Specialty L.p.$19
- Urovant Sciences Inc$18
- plus $17 from 1 others
What the payments were for
- Food & beverage$468100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $185 |
| Avanir Pharmaceuticals, Inc. | 7 | $127 |
| Teva Pharmaceuticals USA, Inc. | 2 | $59 |
| Neurocrine Biosciences, Inc. | 2 | $44 |
| Mylan Specialty L.p. | 1 | $19 |
| Urovant Sciences Inc | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
How this compares
$468 in reported general payments places this provider in the 50th percentile of 933 adult health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 72 | $34,909 |
| Cinacalcet Hcl | 13 | $11,132 |
| MyrbetriqMirabegron | 29 | $10,899 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,519 |
| XareltoRivaroxaban | 12 | $5,682 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $3,601 |
| GemtesaVibegron | 14 | $3,186 |
| Divalproex Sodium | 44 | $2,293 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 56 | $1,889 |
| Potassium Chloride | 66 | $1,593 |
| Gabapentin | 99 | $1,577 |
| Memantine Hcl | 34 | $1,552 |
| Levothyroxine Sodium | 128 | $1,545 |
| Ramelteon | 17 | $1,517 |
| Amlodipine Besylate | 118 | $1,492 |
Paid to pharmacies, not to this prescriber.
Other adult health in Austin
- Elizabeth Wedberg SivamAustin$71K
- Yulia LyuboslavskyAustin$36K
- Meghan MurphyAustin$29K
- Nicole BuschAustin$28K
- Marni MartinezAustin$14K
- Melani DayalAustin$13K
- Laura CalaisAustin$12K
- Shane ConcepcionAustin$10K
- Dorothy DarbyAustin$9K
- Lauren KissockAustin$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.